[1]宋西正 王文军 康禹 王喜莲 周忠群 陈素昌 唐杰 易新 易明.内窥镜联合中药治疗腰椎间盘突出症督脉瘀阻型的临床效果[J].中国中医骨伤科杂志,2018,26(02):45-48.
　SONG Xizheng WANG Wenjun KANG Yu WANG Xilian ZHOU Zhongqun CHEN Suchang TANG Jie YI Xin YI Ming.Clinical Observation of Endoscope Combined with Traditional Chinese Medicine for Treating Lumber Intervertebral Disc Herniation(Du Meridian Stagnation Type)[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2018,26(02):45-48.
点击复制

内窥镜联合中药治疗腰椎间盘突出症督脉瘀阻型的临床效果()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第26卷
期数:
2018年02期
页码:
45-48
栏目:
病证结合,从督论治
出版日期:
2018-01-15

文章信息/Info

Title:
Clinical Observation of Endoscope Combined with Traditional Chinese Medicine for Treating Lumber Intervertebral Disc Herniation(Du Meridian Stagnation Type)
文章编号:
1005-0205(2018)02-0045-04
作者:
宋西正1 王文军1 康禹1 王喜莲1 周忠群1 陈素昌1 唐杰1 易新1 易明1
1南华大学附属第一医院脊柱外科(湖南 衡阳,421001)
Author(s):
SONG Xizheng1 WANG Wenjun1 KANG Yu1 WANG Xilian1 ZHOU Zhongqun1 CHEN Suchang1 TANG Jie1 YI Xin1 YI Ming1
1First Affiliated Hospital of University of South China,Hengyang 421001,Hunan China.
关键词:
督脉瘀阻型;  腰椎间盘突出症;  中药;  内窥镜;  临床效果
Keywords:
Keywords: Du meridian stagnation type;  lumber intervertebral disc herniation;  traditional Chinese medicine;  endoscope;  clinical effect
分类号:
R681.5
文献标志码:
A
摘要:
目的:探讨内窥镜联合中药治疗腰椎间盘突出症(督脉瘀阻型)的临床效果。方法:自2016年1月至2016年7月,选取督脉瘀阻型腰椎间盘突出症的患者68例,分为对照组(内窥镜组)及治疗组(内窥镜加中药组)。比较治疗前、治疗后1个月及末次随访时两组患者疼痛视觉模拟评分(VAS)、下腰痛功能分级评分(FRS)与改良日本骨科学会下腰痛评分(M-JOA)及督脉瘀阻证候积分; 随访时间6～12周。结果:治疗组总有效率为94.18%,对照组为74.47%,两组差异有统计学意义(P<0.05)。两组治疗1个月后和末次随访时,VAS及M-JOA评分与督脉瘀阻证候积分均较治疗前明显下降,FRS评分较治疗前明显增高,差异均有统计学意义(P<0.01)。治疗后1个月时,治疗组的VAS及M-JOA评分与督脉瘀阻证候积分均低于对照组,FRS评分高于对照组,差异均有统计学意义(P<0,05)。至末次随访时治疗组的督脉瘀阻证候积分、VAS与M-JOA评分仍低于对照组,FRS评分高于对照组,差异有统计学意义(P<0.05)。结论:督脉瘀阻型椎间盘突出症内窥镜治疗可解除督脉瘀阻水肿和压迫以疏通督脉,联合中药治疗可改善微循环、消除炎症介质、进一步疏通督脉,以促进功能恢复。
Abstract:
Abstract Objective:To detect the clinical effect of endoscope combined with traditional Chinese medicine for lumbar intervertebral disc herniation(LDH)with Du meridian stagnation type.Methods:All 68 patients with LDH of Du meridian stagnation type were collected from January 2016 to July 2016.All patients were divided into control group(endoscope group)and treatment group(endoscope combined with traditional Chinese medicine),followed-up for 6～12 weeks.The visual analogue pain scale(VAS),the function rating scale for low back pain(FRS),modified Japanese orthopaedic society lower lumbago score(M-JOA)and the syndrome score of Du meridian stagnation of the patients in two groups were compared preoperative,postoperative,1st and the last follow-up respectively.Results:The effective rate of treatment group was 94.18%,the control group was 74.71%(P<0.05).At the time of postoperative,1st month and the last follow-up,the VAS score,the M-JOA score and the syndrome score of Du meridian stagnation of two groups were lower than preoperative,and the FRS score were higher(P<0.01).After treatment for 1 month,the VAS score,the M-JOA score and the syndrome score of Du meridian stagnation of treatment group were lower than control group,and the FRS score were higher than control group(P<0.05).At the last follow-up,the VAS score,the M-JOA score and the syndrome score of Du meridian stagnation of treatment group were still lower than control group,and the FRS score were still higher than control group.Conclusion:The endoscope operation on LDH of Du meridian stagnation type can reduce the edema and remove the compression of the Du meridian.The traditional Chinese medicine can improve the microcirculation,remove inflammatory mediator and dredge Du meridian further so that it can accelerate recovery of spinal nerve's function.

参考文献/References:

[1] Conroy L.Management of severe pain due to lumbar disk protrusion[J].J Pain Palliat Care Pharmacother,2015,29(1):64-66.
[2] 何兴伟,Fadi Salim Saiyaf,谢强.腰椎间盘突出症从温肾通督论治探讨[J].江西中医药,2010,41(330):68-70.
[3] 唐汉武,林一峰,原超,等.温通督脉法治疗退行性腰椎管狭窄症的临床研究[J].时珍国医国药,2016,27(5):1148-1150.
[4] 段小峰,郑汉江,陈俊君,等.椎间孔镜下腰椎间盘髓核摘除术治疗腰椎间盘突出症并发症的临床分析[J].中国疼痛医学杂志,2016,22(9):703-706.
[5] 胡有谷.腰椎间盘突出症[M].3版.北京:人民卫生出版社,2004:3.
[6] 彭宗泽,孙波,李麟平,等.中医药综合治疗腰椎间盘突出症VAS、FRS、改良JOA评分和临床疗效观察[J].中国中医骨伤科杂志,2002,10(6):28-30.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:202-206.
[8] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:人民卫生出版社,1993:130-131.
[9] 贾龙,张华.“治未病”思想指导下腰椎间盘突出症的辨证防治[J].中医正骨,2017,29(1):36-38.
[10] 胥林波.督脉与脊髓的关系探析[J].现代中西医结合杂志,2011,20(30):3844-3845.
[11] 张贺民.督脉论治治疗老年退行性腰椎管狭窄症256例[J].中国中医骨伤科杂志,2013,21(6):14-15.
[12] 谭明生,李显,张恩忠,等.寰枢椎脱位外科治疗与疏通督脉瘀阻相关性研究[J].中国骨伤,2012,25(11):915-919.
[13] 谭明生,齐英娜,姜良海,等.球囊导管构建大鼠督脉瘀阻型上颈脊髓损伤模型的研究[J].中医正骨,2016,28(12):1-5.
[14] 移平,谭明生,吕国华,等.督脉瘀阻型寰枢椎脱位手术联合中药治疗的临床研究[J].中国中医骨伤科杂志,2017,25(1):14-22.
[15] 林一峰,直彦亮,梁组建,等.从督脉论治腰椎间盘突出症的临床研究[J].新中医,2010,42(8):99-100. (收稿日期:2017-10-04)

更新日期/Last Update: 2018-02-15